Cargando…
Valproic Acid: A Promising Therapeutic Agent in Glioma Treatment
Glioma, characterized by infiltrative growth and treatment resistance, is regarded as the most prevalent intracranial malignant tumor. Due to its poor prognosis, accumulating investigation has been performed for improvement of overall survival (OS) and progression-free survival (PFS) in glioma patie...
Autores principales: | Han, Wei, Guan, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461314/ https://www.ncbi.nlm.nih.gov/pubmed/34568018 http://dx.doi.org/10.3389/fonc.2021.687362 |
Ejemplares similares
-
Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53–PUMA Apoptosis Pathway
por: Tsai, Hong-Chieh, et al.
Publicado: (2021) -
Valproic Acid Enhanced Apoptosis by Promoting Autophagy Via Akt/mTOR Signaling in Glioma
por: Han, Wei, et al.
Publicado: (2020) -
Valproic Acid Inhibits Glioma and Its Mechanisms
por: Yang, Zhao-Yu, et al.
Publicado: (2022) -
The Roles of Exosomes as Future Therapeutic Agents and Diagnostic Tools for Glioma
por: Wu, Xiaoben, et al.
Publicado: (2021) -
Molecular dissection of the valproic acid effects on glioma cells
por: Hoja, Sabine, et al.
Publicado: (2016)